Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2022-09-02 00:00:00 ET · period of report 2022-08-31 · accession 0001127602-22-022009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-02 | 2022-08-31 | BCRX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $13.90 | +1,438 | 96.4K | +2% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-31 | A | A | 1,438 | $13.90 | 96,442 | D | — | — | (F1) Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $20,000. |